Elaine Brennan is one of the leaders of True North, a Northwell Health entity established to develop and invest in innovative products, technologies and services that will generate revenue to support the health system’s mission of delivering quality care, innovative research and education.
Ms. Brennan joined Northwell to create Pharma Ventures, a group tasked with establishing an innovative approach to managing and developing more collaborative and strategic relationships with the pharmaceutical industry.
Previously, Ms. Brennan was the CEO of Socrates, a health care information technology company, where she led the development and launch of its electronic health records system in the US. She also worked with Enterprise Ireland, managing the Irish life sciences companies entering the US market and founded also founded Gastroenterology Ireland, which combined a cluster of companies, research and development, and Irish opinion leaders in Ireland and the US.
Her pharmaceutical career at Roche, Bristol Myers Squibb and AbbVie included marketing/sales and clinical roles launching blockbuster products in the virology sector.
Ms. Brennan has published scientific articles on genetic engineering and biodegradable polymers applications, and patented many products in the same area. She earned her science degree in the United Kingdom and her early education in County Galway and Belgium.